Today's Edition
 cluster)
ABU DHABI (ALETIHAD)
The Abu Dhabi Investment Office (ADIO) and the Department of Health – Abu Dhabi (DoH) have partnered with Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) and Hub71 under the emirate’s newly launched Health, Endurance, Longevity, and Medicine (HELM) cluster, advancing Abu Dhabi’s thriving life sciences landscape, and driving a new wave of AI-driven breakthroughs in medicine.
Led by the Abu Dhabi Department of Economic Development (ADDED), ADIO and DoH, the HELM cluster is set to accelerate the research, development, manufacturing, and commercialisation of groundbreaking medicines, biotechnologies, and therapies, with a focus on AI-powered innovation, precision medicine, and personalised treatment.
Announced during Abu Dhabi Global Health Week (ADGHW), this partnership will advance the cluster’s efforts to develop an AI-powered discovery ecosystem that aims to accelerate the development of new medicines. The initiative provides support to develop scalable infrastructure for managing and analysing complex healthcare data, including clinical, genomic, and proteomic datasets, leveraging Abu Dhabi-based companies’ expertise in healthcare services and data management.
Partners will also work together to fast-track intellectual property development while supporting the commercialisation of breakthrough healthcare solutions in the emirate of Abu Dhabi. Companies seeking to co-develop AI-powered discovery solutions will benefit from ADIO’s competitive business support to establish operations within Abu Dhabi’s HELM cluster and scale globally.
Dr. Noura Khamis Al Ghaithi, Undersecretary of DoH, said: “AI and data are today’s enablers of smarter, predictive, preventive, and more personalised care. Through the HELM cluster, we are building a globally connected ecosystem that empowers researchers, innovators, and investors to unlock the full potential of data-driven discovery. From early diagnostics to personalised therapies, Abu Dhabi is positioning itself as a hub where cutting-edge science meets real-world impact.”
For his part, Badr Al-Olama, Director General of ADIO, said: “By integrating AI-driven research and innovation within the HELM cluster, we are not only accelerating drug discovery and precision medicine, we are advancing Abu Dhabi’s position as a leader in the digital healthcare transformation. The cluster is a launchpad for groundbreaking solutions that will shape the future of how diseases are detected, how treatment is delivered and how health is managed worldwide. This collaboration exemplifies Abu Dhabi’s ability to bring together world-class institutions,
